MICHAEL G. GREY - 28 Apr 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
Director
Signature
/s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol
HZNP
Transactions as of
28 Apr 2022
Transactions value $
-$112,260
Form type
4
Filing time
02 May 2022, 18:06:36 UTC
Previous filing
20 Dec 2021
Next filing
27 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Options Exercise +4.22K +6.78% 66.5K 29 Apr 2022 By Trust F1
transaction HZNP Ordinary Shares Tax liability -$112K -1.14K -1.71% $98.56 65.4K 29 Apr 2022 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Restricted Stock Units Award $0 +3.91K $0.00 3.91K 28 Apr 2022 Ordinary shares 3.91K Direct F1
transaction HZNP Restricted Stock Units Options Exercise $0 -4.22K -100% $0.00* 0 29 Apr 2022 Ordinary shares 4.22K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.